Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nea K. Malila"'
Autor:
Hanna A.M. Koivisto, Aapeli O. Nevala, Joonas M. Miettinen, Janne M. Pitkäniemi, Nea K. Malila, Sanna M.M. Heikkinen
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background and purpose: The objective of this study was to explore the incidence of second malignant neoplasms (SMNs) among adult cancer patients in Finland diagnosed with their first primary cancer (FPC) in 1992–2021. Material and methods: The st
Externí odkaz:
https://doaj.org/article/22c9806678434095b63f86d80269ac3b
Autor:
Jasmiina N. J. Rantala, Sanna M. M. Heikkinen, Elli M. Hirvonen, Tomas Tanskanen, Nea K. Malila, Janne M. Pitkäniemi
The risk of early-onset (EO) breast cancer is known to be increased in relatives of EO breast cancer patients, but less is known about the familial risk of other EO cancers. We assessed familial risks of EO cancers (aged ≤40 years) other than breas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32ea5355bf4664cf6bc75841ff96fc42
http://hdl.handle.net/10138/358076
http://hdl.handle.net/10138/358076
Autor:
Johanna Melin, Nea K. Malila, Viivi I. Seppänen, Mika Gissler, Janne Pitkäniemi, Laura-Maria S. Madanat-Harjuoja, Tiina Ylöstalo
Publikováno v:
CancerReferences. 127(9)
Background The relative probability of pregnancy and parenthood in cancer survivors is reduced. Studies have shown that cancer survivors are concerned about the health of their offspring and the recurrence of their own cancer. This could lead to an i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a417a4fe5da1801291b922a9857e3ad
https://pubmed.ncbi.nlm.nih.gov/33491215
https://pubmed.ncbi.nlm.nih.gov/33491215
Risk for congenital anomalies in offspring of childhood, adolescent and young adult cancer survivors
Autor:
Viivi I, Seppänen, Miia S, Artama, Nea K, Malila, Janne M, Pitkäniemi, Matti E, Rantanen, Annukka K, Ritvanen, Laura-Maria, Madanat-Harjuoja
Publikováno v:
International journal of cancer. 139(8)
Offspring of cancer survivors (CS) may be at risk for congenital anomalies due to the mutagenic therapies received by their parents. Our population-based cohort study aimed to investigate the risk for congenital anomalies in offspring of CS compared
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a9e4dd6f1688990f4c8026ed7fdb825a
https://pubmed.ncbi.nlm.nih.gov/27280956
https://pubmed.ncbi.nlm.nih.gov/27280956